as on November 6, 2025 at 2:29 am IST
Day's Low
Day's High
2.59%
Downside
1.07%
Upside
52 Week's Low
52 Week's High
96.73%
Downside
-96.73%
Upside
Check Idexx Laboratories, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$57.8B
EPS (TTM)
12.7296
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.49%
PE Ratio (TTM)
60.24
Industry PE ratio
19.200384615384614
PEG Ratio
4.2238
EBITDA
1.4B
Revenue (TTM)
4.0B
Profit Margin
24.41%
Return On Equity TTM
64.87%
Track how Idexx Laboratories, Inc. P/E has moved over time to understand its valuation trends.
Idexx Laboratories, Inc. in the last 5 years
Lowest (38.09x)
March 31, 2025
Industry (19.20x)
November 5, 2025
Today (60.24x)
November 5, 2025
Highest (79.24x)
September 30, 2021
Today’s Price to Earnings Ratio: 60.24x
Compare market cap, revenue, PE, and other key metrics of Idexx Laboratories, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $57.8B | 54.31% | 60.24 | 24.41% | |
| BUY | $212.2B | 9.81% | 32.67 | 15.02% | |
| BUY | $41.0B | 32.39% | 33.81 | 17.97% | |
| BUY | $35.9B | 22.86% | 29.02 | 8.07% | |
| BUY | $151.2B | -11.03% | 44.05 | 14.44% |
The Idexx Laboratories, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Idexx Laboratories, Inc. investment value today
Current value as on today
₹1,78,504
Returns
₹78,504
(+78.5%)
Returns from Idexx Laboratories, Inc. Stock
₹73,153 (+73.15%)
Dollar Returns*
₹5,351 (+5.35%)
Based on 19 analysts
68.42%
Buy
31.58%
Hold
0.00%
Sell
Based on 19 analysts, 68.42% of analysts recommend a 'BUY' rating for Idexx Laboratories, Inc.. Average target price of $727.17
Get share price movements and forecasts by analysts on Idexx Laboratories, Inc..
What analysts predicted
0.95%UPSIDE
Target Price
$727.17
Current Price
$720.28
Analyzed by
19 Analysts
Target
$727.17
Idexx Laboratories, Inc. target price $727.17, a slight upside of 0.95% compared to current price of $720.28. According to 19 analysts rating.
Search interest for Idexx Laboratories, Inc. Stock has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 04 November
Tue, 04:52 PM
-IDXX surged over 14%, becoming the top gainer on S&P 500 after positive Q3 results and raised full-year guidance.
Tue, 05:33 PM
-BTIG maintains Buy recommendation for IDXX, with average price target at $697.54, despite a slight decrease from the latest closing price.
Tue, 05:42 PM
-Analysts raise IDXX's price target, reflecting confidence in growth momentum and strong Q3 results.
Today's Timeline - 04 November
Tue, 08:05 PM
-IDXX shows bullish technical signals, with positive earnings estimate revisions supporting a potential rally.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, IDXX stock has moved up by 14.9%
Best in 1 Year
![]()
In the last 1 year, IDXX has outperformed top 5 stocks with highest market-cap in its industry
Best in 3 Years
![]()
In the last 3 years, IDXX has outperformed top 5 stocks with highest market-cap in its industry
Profit Down
![]()
Idexx Laboratories, Inc. has experienced a decline in net profit over the last two quarters, dropping from $293.98 million to $274.61 million. This represents an average decrease of 6.6% per quarter.
Revenue Fall
![]()
Idexx Laboratories, Inc. has experienced a decline in revenue over the last two quarters, with revenue remaining at $1.10 billion. This period saw an average decrease of 0.4% per quarter.
| Organisation | Idexx Laboratories, Inc. |
| Headquarters | One IDEXX Drive, Westbrook, ME, United States, 04092 |
| Industry | Health Technology |
| CEO | Mr. Jonathan J. Mazelsky |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Sharon E. Underberg J.D. | Executive VP, General Counsel, & Corporate Secretary |
Ms. Julie Godon | Senior VP & Global Marketing Officer |
Mr. Michael P. Johnson | Executive VP & Chief Human Resources Officer |
Mr. Jonathan J. Mazelsky | President, CEO & Director |
Mr. Michael J. Lane | Executive VP and GM Global Reference Laboratories, Diagnostic Solutions & Information Technology |
Dr. Nimrata Khatra Hunt P.E., Ph.D. | Executive Vice President of Global Strategy & Commercial |
Mr. George J. Fennell | Executive Vice President of Global CAG Commercial |
Dr. Martin Smith Ph.D. | Executive Vice President of Global Operations and R&D |
Mr. Andrew Emerson | Executive VP, CFO & Treasurer |
Mr. Bob Asmann | Senior Vice President of Global Operations |
Idexx Laboratories, Inc. share price today is $720.28 as on at the close of the market. Idexx Laboratories, Inc. share today touched a day high of $727.97 and a low of $701.61.
Idexx Laboratories, Inc. share touched a 52 week high of $23.58 on and a 52 week low of $23.56 on . Idexx Laboratories, Inc. stock price today i.e. is closed at $720.28,which is -2954.62% down from its 52 week high and 2957.22% up from its 52 week low.
Idexx Laboratories, Inc. market capitalisation is $0.06T as on .
Indian investors can start investing in Idexx Laboratories, Inc. (IDXX) shares with as little as ₹88.615 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.15 in Idexx Laboratories, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Idexx Laboratories, Inc. share’s latest price of $720.28 as on November 6, 2025 at 2:29 am IST, you will get 0.0139 shares of Idexx Laboratories, Inc.. Learn more about
fractional shares .
Idexx Laboratories, Inc. stock has given 54.31% share price returns and 20.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?